Knowable, Noble

Three days after an outstanding AMA-Houston Healthcare SIG seminar at Rice University, Houston pediatrician Dr Ana Malinow wrote in the Houston Chronicle about treating a six-year-old girl in a public clinic:

When I saw her, her hand was swollen to twice the normal size, purple, tender and warm to the touch, with a red streak (signifying an extension of…infection…to the bloodstream)…she was uninsured and had been sent home with a prescription that her mother tried to fill but was unable to afford. How much did the antibiotic…cost? $500.

The four speakers who addressed “Marketing Healthcare under a New Administration” were effective and humorous. Passionate. Completely engaged with almost 100 attendees. Each one lit up a different facet of the American healthcare system in crisis…a phrase that’s still stabbingly relevant as Malinow’s op-ed letter makes clear.

The nature of this blog makes it difficult to condense two hours of presentations and QAs into a few paragraphs. Still, I’m revisiting the event because of the high quality of the presentations.

Dr Lewis Foxhall, President of the Harris County Medical Society, delivered the overview and laid the foundations of the case, quickly but effectively covering present circumstances.

Memorial City Medical Center’s Tim Schauer addressed policy issues and made the case that pay-for-performance will never work because medicine is still a “practice.” He also spotlighted the nature of special interests.

Houston Wellness Association president Jonathan Lack portrayed wellness as key player in prospective solutions, emphasizing that workplace wellness is a productivity tool. He vividly revealed portrayed the challenges of community and public health. Lack contends that today’s medical center is a sick-care model and it’s considerably overburdened.

Yaffe Deutser’s President/COO, Brad Deutser, concluded with what might be called the “capitalist model” of marketing healthcare: The state of the economy isn’t going to change the number of affluent people but will change what the affluent people buy from doctors and dentists. He suggests that marketing effectiveness will still be an organizational survival mechanism, targeting more profitable prospects.

In presenting, Deutser unconsciously set the tone for my morning. One of his premises was, all target prospect information can be found – “Today, everything is knowable.” What I heard the first few times Deutser said this is, “Today, everything is noble.”

Compared to healthcare in some parts of the world, America has arguably progressed only slowly to noble. The most valuable transformation under the new administration in Washington, then, is redefining how our people deserve and receive healthcare.

My big takeaway from Thursday’s marketing seminar is that marketers can take more of a role, a noble role, in fostering improved healthcare access.

In an issue with so very many stakeholders (doctors, community activists, “ordinary” people, to name only a few), I want us to make it more. Don’t ask me how, yet. It can’t be just about the ads – or the brands. It’s can’t be just about knowing.

A survey’s being conducted now – if you’re invited to participate, fill it out please. I’ll report the results. Extra thanks to the quite large number of people who made this SIG event a success. Event photos by Suzanne Jarvis at Shutterfly. Graphic courtesy of Aceofhearts1968, Wikimedia.

Deutser Preview

Talking in advance of this Friday’s AMA Healthcare SIG seminar, Brad Deutser thinks the new administration approach to American medical care is going to require a fundamental shift in how healthcare institutions communicate with – and market to – their customers.

“But we don’t know yet what the new policies will be,” he says. “The immediate challenges are underinsured and uninsured customers…more proactive recognition of this fact will lead the greatest value while serving a given institution’s mission.”

You can hear his take on what’s ahead when you join us Friday at Rice University. Click here for registration.

Photo: David A Farias/Houston Business Journal.

Healthcare Change?

In 1957, Parke, Davis felt that public perception of the high cost of a prescription was so negative, the drug company created and ran ads like this one. The dad on the left is shocked – shocked – that his buddy “…paid $9.00 to get that one prescription filled? Wow!”

Today, if you can get a prescription filled for $9, you feel like you’ve hit the jackpot. Today, we get a new administration in Washington that’s pledged to “do something” about healthcare in America.

So next week, AMA-Houston’s Healthcare Marketing SIG is putting on a big seminar: “Marketing Healthcare under a New Administration.” If you have anything to do with marketing, selling or advertising healthcare services and products, you better be signing up here.

The day and date: Friday, 27 February at 7.30 AM – the SIG’ll have a coffee-and-pastry bar set out for you. The location, Rice University’s Anderson Family Commons (Rice Blvd and Main, Entrance 20), is exactly the right venue for what we hope’s going to be a provocative mixture of marketing and public policy.

The seminar panelists include marketing executive Brad Deutser of Yaffe Deutser; Houston Wellness Association president Jonathan Lack; Lewis Foxhall, MD, President of the Harris County Medical Society; and Tim Schauer, Memorial Hermann Healthcare System. They are going to help us envision the policy changes and marketing challenges that healthcare marketers will have to face in the next four years.

One point we made in the event’s write-up is that American medicine is a business (the Parke, Davis drug ad underscores that). But it’s a business that’s significantly affected by national healthcare policy. Marketing is “downstream” of policy; it’s critical on an operational or tactical level. You don’t think so? Check out Parke, Davis’s ad copy: “…you appreciate what good value you’re getting.”

That’s a hard, hard case to make 50+ years later. Today, nobody feels they’re getting bargains. Sign up now. Maybe you’ll find out how to change your prospects’ thinking.

Parke, Davis & Company is now a subsidiary of the pharmaceutical company Pfizer. Ad #MM0340, Medicine and Madison Avenue On-Line Project, John W. Hartman Center for Sales, Advertising & Marketing History,Rare Book, Manuscript, and Special Collections. Thanks.